APR 05, 2017 6:00 AM PDT

A workflow for CRISPR-Cas9 high throughput arrayed screening with synthetic crRNA

Speaker
  • Senior Product Manager, GE Healthcare
    Biography
      The speaker is Louise Baskin, MS, senior product manager, GE Healthcare. Louise, who joined Dharmacon RNA Technologies in 2005, has led the development and commercial launch of multiple genome-wide siRNA and microRNA product lines. She is also responsible for developing and expanding the Dharmacon Edit-R Genome Engineering portfolio, which includes synthetic crRNA and lentiviral sgRNA, in addition to Cas9 nucleases in inducible or constitutive lentiviral vectors, DNA plasmid, mRNA, or protein formats. She works closely with a respected team of R&D scientists on innovative CRISPR-Cas9 tools and services. Louise earned a master's degree in molecular biology and genetics at Northwestern University.

    Abstract

    There is rapidly growing interest in using the CRISPR-Cas9 system for functional screening, both as a primary screening tool and as an orthogonal tool for RNAi hit validation. High throughput synthesis, combined with a proprietary algorithm that selects highly functional and specific guide RNAs, allows rapid generation of CRISPR RNA (crRNA) collections in arrayed formats. Arrayed crRNA screens offer the advantage of applying sophisticated assays, such as those requiring high-content microscopy, to investigate phenotypes that involve intracellular localization, morphological changes, or require time-lapse investigation. While pooled lentiviral sgRNA screens have demonstrated utility for loss-of-function studies, the types of assays used are typically limited to viability, sensitization, and some reporter assays. We will demonstrate the application of arrayed screening with synthetic crRNA libraries across multiple assay types, and present considerations for experimental success.


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    MAR 16, 2021 10:00 AM PDT
    C.E. CREDITS
    MAR 16, 2021 10:00 AM PDT
    Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
    DEC 15, 2020 10:00 AM PST
    C.E. CREDITS
    DEC 15, 2020 10:00 AM PST
    DATE: December 15, 2020 TIME: 10:00am PST Scientists from Thermo Fisher Scientific will walk us through the world of microorganisms. They will discuss their most recent research on viruses,...
    APR 05, 2017 6:00 AM PDT

    A workflow for CRISPR-Cas9 high throughput arrayed screening with synthetic crRNA


    Specialty

    Cancer Research

    Biotechnology

    Molecular Biology

    Cell Biology

    Genetics

    Biochemistry

    Cell Culture

    Gene Expression

    Immunology

    Genomics

    Biomarkers

    Cancer Therapeutics

    Molecular Diagnostics

    Cancer Diagnostics

    Crispr-Cas9

    Geography

    North America53%

    Europe24%

    Asia16%

    South America4%

    Africa2%

    Oceania1%

    Registration Source

    Website Visitors100%

    Job Title

    Research Scientist18%

    Scientist15%

    Student15%

    Post Doc12%

    Executive10%

    Educator/Faculty8%

    Facility/Department Manager7%

    Medical Doctor/Specialist7%

    Engineer2%

    Medical Laboratory Technician2%

    Consultant1%

    Lab Management1%

    Biologist1%

    Marketing/Sales1%

    Organization

    Academic Institution12%

    Ambulatory Care5%

    Research Institute5%

    Biotech Company5%

    Pharmaceutical Company2%

    Medical School2%

    Hospital2%

    Life Science Company2%

    Medical Center2%

    Industrial Company1%

    Government1%

    Clinical Laboratory1%

    Non-Profit Organization1%

    Consultant1%

    Other4%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more